Physician

Jeffrey K Moore, MD

According to 2025 Medicare claims, Jeffrey Moore, MD (NPI: 1518963677) practices ophthalmology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from Cumberland, ME. This provider's primary affiliated billing organization is MAINE EYE CENTER, PA (NPI: 1720044878; TIN: 01-0329291) and primary practice location at 04101-2438. Moore is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), participating under the MSSP model.

Moore's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 681 traditional Medicare patients, billed 43,685 HCPCS/CPT codes, and received $3,566,315 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 955 prescription claims across 304 beneficiaries totaling $62,247 in drug costs, led by Pred Forte (Prednisolone Acetate). Open Payments data shows 47 records totaling $165,487. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $41,296 to $62,247. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $2,675,911 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,285,636 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,106,769 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,160,851 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,157,243 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,812,747 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,743,558 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,757,457 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,956,815 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,566,315 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158009,868$2,675,911
201696311,920$3,285,636
201797511,484$3,106,769
201889312,120$3,160,851
201985911,349$3,157,243
20207839,431$2,812,747
20217489,350$2,743,558
202287213,460$2,757,457
202372129,602$2,956,815
202468143,685$3,566,315

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$51K$102K2015 Drug cost: $41,296 (USD; Tot_Drug_Cst)2016 Drug cost: $43,261 (USD; Tot_Drug_Cst)2017 Drug cost: $50,908 (USD; Tot_Drug_Cst)2018 Drug cost: $74,046 (USD; Tot_Drug_Cst)2019 Drug cost: $92,670 (USD; Tot_Drug_Cst)2020 Drug cost: $87,786 (USD; Tot_Drug_Cst)2021 Drug cost: $102,179 (USD; Tot_Drug_Cst)2022 Drug cost: $96,099 (USD; Tot_Drug_Cst)2023 Drug cost: $78,898 (USD; Tot_Drug_Cst)2024 Drug cost: $62,247 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015154365$41,296
2016216511$43,261
2017216511$50,908
2018222752$74,046
2019240923$92,670
2020257850$87,786
2021293954$102,179
2022276930$96,099
2023251804$78,898
2024304955$62,247

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2091,894$647
67028Injection of drug into eye3631,711$109
92014Established patient complete exam of visual system6061,005$98
92134Imaging of retina5631,123$32
92250Photography of the retina202254$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Pred FortePrednisolone Acetate15404$9,039
Prednisolone AcetatePrednisolone Acetate2519,632$7,707
LumiganBimatoprost12659$6,729
Alphagan PBrimonidine Tartrate24949$5,911
CombiganBrimonidine Tartrate/Timolol19985$4,728

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.20$9,183Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.26$156,304Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.1$8,518US Retina LLC

FAQ

What Medicare data is available for Jeffrey K. Moore, MD?

Tedicare shows public-source Medicare data for Jeffrey K. Moore, MD (NPI 1518963677), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey K. Moore, MD have ACO affiliation data?

Jeffrey K. Moore, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290).

What billing organization is linked to Jeffrey K. Moore, MD?

Jeffrey K. Moore, MD is linked to MAINE EYE CENTER, PA (billing NPI 1720044878) in the available physician profile data.

Does Jeffrey K. Moore, MD have Open Payments data?

Jeffrey K. Moore, MD has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.